Search Results - Robert C. Doebele

Refine Results
  1. 1
    Targeted Therapies in Non-Small Cell Lung Cancer: Emerging Oncogene Targets Following the Success of Epidermal Growth Factor Receptor

    Targeted Therapies in Non-Small Cell Lung Cancer: Emerging Oncogene Targets Following the Success of Epidermal Growth Factor Receptor by Eamon M. Berge, Robert C. Doebele

    Published 2013
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Treating ALK-positive lung cancer—early successes and future challenges

    Treating ALK-positive lung cancer—early successes and future challenges by D. Ross Camidge, Robert C. Doebele

    Published 2012
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Molecular Pathways: ROS1 Fusion Proteins in Cancer

    Molecular Pathways: ROS1 Fusion Proteins in Cancer by Kurtis D. Davies, Robert C. Doebele

    Published 2013
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    A framework for understanding and targeting residual disease in oncogene-driven solid cancers

    A framework for understanding and targeting residual disease in oncogene-driven solid cancers by Trever G. Bivona, Robert C. Doebele

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    TRKing Down an Old Oncogene in a New Era of Targeted Therapy

    TRKing Down an Old Oncogene in a New Era of Targeted Therapy by Aria Vaishnavi, Anh‐Tuan Le, Robert C. Doebele

    Published 2014
    Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    PrlA and PrlG suppressors reduce the requirement for signal sequence recognition

    PrlA and PrlG suppressors reduce the requirement for signal sequence recognition by Ann M. Flower, Robert C. Doebele, Thomas J. Silhavy

    Published 1994
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Determination of the HLA-DM Interaction Site on HLA-DR Molecules

    Determination of the HLA-DM Interaction Site on HLA-DR Molecules by Robert C. Doebele, Robert Busch, Hyman M. Scott, Achal Pashine, Elizabeth Mellins

    Published 2000
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Adding to the Mix: Fibroblast Growth Factor and Platelet-Derived Growth Factor Receptor Pathways as Targets in Non – small Cell Lung Cancer

    Adding to the Mix: Fibroblast Growth Factor and Platelet-Derived Growth Factor Receptor Pathways as Targets in Non – small Cell Lung Cancer by Scott A. Kono, Lynn E. Heasley, Robert C. Doebele, D. Ross Camidge

    Published 2012
    Get full text
    Revisão
    Save to List
    Saved in:
  9. 9
    A Changing of the Guard: Immune Checkpoint Inhibitors With and Without Chemotherapy as First Line Treatment for Metastatic Non-small Cell Lung Cancer

    A Changing of the Guard: Immune Checkpoint Inhibitors With and Without Chemotherapy as First Line Treatment for Metastatic Non-small Cell Lung Cancer by Jose M. Pacheco, D. Ross Camidge, Robert C. Doebele, Erin L. Schenk

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  10. 10
    Diagnostic assays for identification of anaplastic lymphoma kinase‐positive non–small cell lung cancer

    Diagnostic assays for identification of anaplastic lymphoma kinase‐positive non–small cell lung cancer by Andrew Weickhardt, Dara L. Aisner, Wilbur A. Franklin, Marileila Varella‐Garcia, Robert C. Doebele, D. Ross Camidge

    Published 2012
    Get full text
    Revisão
    Save to List
    Saved in:
  11. 11
    Anthrax Edema Toxin Inhibits Endothelial Cell Chemotaxis via Epac and Rap1

    Anthrax Edema Toxin Inhibits Endothelial Cell Chemotaxis via Epac and Rap1 by Jia Hong, Robert C. Doebele, Mark W. Lingen, Lawrence A. Quilliam, Wei‐Jen Tang, Marsha Rich Rosner

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Stereotactic Radiation Therapy can Safely and Durably Control Sites of Extra-Central Nervous System Oligoprogressive Disease in Anaplastic Lymphoma Kinase-Positive Lung Cancer Patients Receiving Crizotinib

    Stereotactic Radiation Therapy can Safely and Durably Control Sites of Extra-Central Nervous System Oligoprogressive Disease in Anaplastic Lymphoma Kinase-Positive Lung Cancer Pati... by Gregory N. Gan, Andrew Weickhardt, Benjamin Scheier, Robert C. Doebele, Laurie E. Gaspar, Brian D. Kavanagh, D. Ross Camidge

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Interaction of HLA-DR with an Acidic Face of HLA-DM Disrupts Sequence-Dependent Interactions with Peptides

    Interaction of HLA-DR with an Acidic Face of HLA-DM Disrupts Sequence-Dependent Interactions with Peptides by Achal Pashine, Robert Busch, Michael P. Belmares, Jason N. Munning, Robert C. Doebele, Megan Buckingham, Garry P. Nolan, Elizabeth Mellins

    Published 2003
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    An Activating KIT Mutation Induces Crizotinib Resistance in ROS1-Positive Lung Cancer

    An Activating KIT Mutation Induces Crizotinib Resistance in ROS1-Positive Lung Cancer by Rafał Dziadziuszko, Anh T. Le, Anna Wrona, Jacek Jassem, D. Ross Camidge, Marileila Varella‐Garcia, Dara L. Aisner, Robert C. Doebele

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Rapid‐onset hypogonadism secondary to crizotinib use in men with metastatic nonsmall cell lung cancer

    Rapid‐onset hypogonadism secondary to crizotinib use in men with metastatic nonsmall cell lung cancer by Andrew Weickhardt, Micol S. Rothman, Smita Salian‐Mehta, Katja Kiseljak‐Vassiliades, Ana B. Oton, Robert C. Doebele, Margaret E. Wierman, D. Ross Camidge

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    A phase I, open-label dose-escalation study of continuous treatment with BIBF 1120 in combination with paclitaxel and carboplatin as first-line treatment in patients with advanced non-small-cell lung cancer

    A phase I, open-label dose-escalation study of continuous treatment with BIBF 1120 in combination with paclitaxel and carboplatin as first-line treatment in patients with advanced... by Robert C. Doebele, Paul Conkling, Anne M. Traynor, Gregory A. Otterson, Yanyan Zhao, Sven Wind, Peter Stopfer, R. Kaiser, D. Ross Camidge

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Dramatic Response to Crizotinib in a Patient With Lung Cancer Positive for an <i>HLA-DRB1-MET</i> Gene Fusion

    Dramatic Response to Crizotinib in a Patient With Lung Cancer Positive for an <i>HLA-DRB1-MET</i> Gene Fusion by Kurtis D. Davies, Terry L. Ng, Adriana Estrada‐Bernal, Anh T. Le, Peter R. Ennever, D. Ross Camidge, Robert C. Doebele, Dara L. Aisner

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Optimizing the Detection of Lung Cancer Patients Harboring Anaplastic Lymphoma Kinase (<i>ALK</i>) Gene Rearrangements Potentially Suitable for ALK Inhibitor Treatment

    Optimizing the Detection of Lung Cancer Patients Harboring Anaplastic Lymphoma Kinase (<i>ALK</i>) Gene Rearrangements Potentially Suitable for ALK Inhibitor Treatment by D. Ross Camidge, Scott A. Kono, Antonella Flacco, Aik Choon Tan, Robert C. Doebele, Qing Zhou, Lucio Crinò, Wilbur A. Franklin, Marileila Varella‐Garcia

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Exploratory analysis of the association of depth of response and survival in patients with metastatic non-small-cell lung cancer treated with a targeted therapy or immunotherapy

    Exploratory analysis of the association of depth of response and survival in patients with metastatic non-small-cell lung cancer treated with a targeted therapy or immunotherapy by Caroline E. McCoach, Gideon M. Blumenthal, L. Zhang, Adrian Myers, Shenghui Tang, R. Sridhara, Patricia Keegan, Richard Pazdur, Robert C. Doebele, Dickran Kazandjian

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Comparison of Molecular Testing Modalities for Detection of ROS1 Rearrangements in a Cohort of Positive Patient Samples

    Comparison of Molecular Testing Modalities for Detection of ROS1 Rearrangements in a Cohort of Positive Patient Samples by Kurtis D. Davies, Anh‐Tuan Le, Jamie Sheren, Hala Nijmeh, Katherine Gowan, Kenneth L. Jones, Marileila Varella‐Garcia, Dara L. Aisner, Robert C. Doebele

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: